The Ministry of Health began the second phase ofhuman trials at the healthcare centre of Ben Luc district on February 26.
The volunteers, chosen from more than 800 peoplewho registered to take part, consist of two age groups: from 18 to 60 and over60.
They will receive two doses of either thevaccine or the placebo AIPO4, with an interval of 28 days. Each volunteer willbe monitored for 12 months after the first dose.
Volunteers receiving jabs on the morning of February26 will receive the second dose in late March.
The research outcomes of these second-phasetrials will be available in late April.
The second stage human trials of Nano Covax are alsounderway in Hanoi.
Developed by the Nanogen PharmaceuticalBiotechnology JSC and the Hanoi-based Military Medical University, Nano Covaxis Vietnam’s first COVID-19 vaccine to reach the human trial stage.
According to a representative from the university,a total of 560 volunteers, including those with other ailments such ashypertension or diabetes, among others, will participate in the second-stagetrials in both localities.
Lieutenant-General Do Quyet, Director of theMilitary Medical University, said that since the trial is seeing the participationof volunteers with underlying health conditions, relevant authorities are preparedfor all possible scenarios and will ensure the safety of all volunteers.
The first-stage trial of the Nano Covax vaccineshowed that it is likely to be effective against the B117 variant from the UK.
Vietnam is one of 40 countries and territories inthe world to have begun human trials of a COVID-19 vaccine, after successfullyproducing coronavirus test kits early in the pandemic.
The country also has other COVID-19 candidatevaccines being developed: IVAC from the Institute of Vaccines and MedicalBiologicals, VABIOTECH from the Company for Vaccine and Biological ProductionNo 1, and POLYVAC from the Centre for Research and Production of Vaccines andBiologicals./.